mutations specified The truth that, as spelled out below, CLL therapy is predicated to the presence or absence of those mutations. The current consensus is, aside from clonal mutations, subclonal mutations with a variant allelic frequency starting from five to ten% (and thus down below the threshold of detection by conventional molecular strategies